catecholamine
Small moleculeexperimental
A catecholamine, most typically a 3,4-dihydroxyphenethylamine, is a monoamine neurotransmitter, an organic compound that has a catechol and a side-chain amine. — Wikipedia
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT00795366)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCatecholamine ↗
Also known as
- catecholamine
- catecholamine
- catecholamines
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03118024 | N/A | Mar 13, 2017 | University of Regensburg |
| NCT00795366 | N/A | Sep 1, 2008 | University of Miami |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Miami | Academic/Hospital | 1 | 1 | 1 | 2008 |
| University of Regensburg | Academic/Hospital | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1